| Foreign stocks | 100.00% |
Update date: 2/27/2026
| United States Dollar | 74.46% |
| Swiss Franc | 12.97% |
| British Pound | 6.38% |
| Japanese Yen | 2.46% |
| Danish Krone | 2.16% |
| Euro | 1.04% |
| Chinese Yuan | 0.54% |
Update date: 3/31/2026
| North America | 71.62% |
| Europe | 25.39% |
| Asia Pacific | 3.00% |
Update date: 3/31/2026
| Health Care | 92.91% |
| INDUSTRIALS | 4.69% |
| INFORMATION TECHNOLOGY | 1.43% |
| Not Available | 0.83% |
| FINANCIALS | 0.14% |
Update date: 3/31/2026
| Eli Lilly & Co. | 9.23% |
| Novartis AG (REG) | 6.14% |
| AstraZeneca PLC | 6.11% |
| Roche Holding AG | 5.44% |
| Gilead Sciences, Inc. | 4.56% |
| AbbVie, Inc. | 4.33% |
| UnitedHealth Group, Inc. | 4.00% |
| Intuitive Surgical, Inc. | 3.63% |
| Stryker Corp. | 3.63% |
| Vertex Pharmaceuticals, Inc. | 3.52% |
Update date: 3/31/2026